Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K191065
    Device Name
    Venus VivaTM
    Date Cleared
    2020-04-01

    (345 days)

    Product Code
    Regulation Number
    878.4400
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Venus VivaTM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Venus Viva™ Device is a non-invasive device intended to be used by aesthetic physicians or dermatologists.

    When used with the Diamondpolar applicator, the Venus Viva™ Device is intended for use in dermatological and surgical procedures for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin type I-IV.

    When used with the Viva applicator, the Venus Viva™ Device is intended for use in dermatological procedures requiring ablation and resurfacing of the skin.

    Device Description

    The Venus Viva™ device consists of a console (main unit) and two applicators – Viva and Diamondpolar. The console contains a power supply unit, an RF generator (power module, on main board), a controller unit (on main board) and a touchscreen user interface and display panel.

    The Venus Viva™ device is a combination of the previously cleared Venus Viva™ SR (K150161), the primary predicate, and the Diamondpolar applicator that was previously cleared for the secondary predicate Venus Legacy BX (K142910). Both the Viva and Diamondpolar applicators can now be connected simultaneously to a single console, the Venus Viva™ console.

    AI/ML Overview

    The Venus Viva™ Device is a non-invasive device intended for use by aesthetic physicians or dermatologists. It is designed for dermatological and surgical procedures, specifically for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV (when used with the Diamondpolar applicator) and for ablation and resurfacing of the skin (when used with the Viva applicator).

    Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The submission does not explicitly list "acceptance criteria" in a typical quantitative clinical performance metric sense (e.g., sensitivity, specificity, accuracy for a diagnostic device). Instead, it focuses on demonstrating substantial equivalence to predicate devices by meeting performance standards, electrical safety, biocompatibility, and software validation. The key acceptance criteria are implicitly that the new device performs at least as well as, and has similar safety and effectiveness profiles as, the predicate devices.

    Acceptance Criteria (Implicit)Reported Device Performance
    Performance Bench Testing: RF and PMF Output Parameters & Temperature StabilityDemonstrated that the Venus Viva™ device has the same RF and PMF output specifications and temperature stability profile as the predicate device (Venus Viva™ SR K150161).
    Electrical Safety Standards CompliancePassed tests according to: IEC 60601-1 (Ed. 3.1, 2012), IEC 60601-1-2 (Fourth Edition, 2014), IEC 60601-2-2 (Sixth Edition, 2017), IEC 60601-1-6 (Third Edition, 2013).
    Electromagnetic Compatibility (EMC) Standards CompliancePassed tests according to: IEC 60601-1-2 (Fourth Edition, 2014).
    Software ValidationSoftware underwent verification and validation testing, and results demonstrated that the system performed as intended, complying with IEC 62304 (Ed. 1.1, 2015).
    Sterilization & Cleaning EfficacyDiamondpolar applicator cleaning/disinfection instructions previously validated for predicate (Venus Legacy BX K142910). Viva applicator tip steam sterilization instructions previously validated for predicate (Venus Viva™ SR K150161).
    BiocompatibilityPatient-contacting components (Viva applicator tips, Diamondpolar electrodes) tested for cytotoxicity, sensitization, and irritation/intracutaneous reactivity per FDA guidance and ISO 10993-1. All materials determined biocompatible for intended use.
    Similar Intended Use and Indications for UseThe Venus Viva™ device has the same intended use and a combination of the indications of the previously cleared Venus devices.
    Similar Technological Characteristics & Principles of OperationSimilar console design, components, and energy delivery (RF and PMF) to predicate devices.
    Similar Safety and Effectiveness ProfileSafety features, compliance with safety standards, patient contact materials, treatment methods, energy levels, treatment area, and durations are similar to predicate devices.

    2. Sample Size Used for the Test Set and Data Provenance

    The provided document describes engineering and laboratory performance testing, not a clinical study involving human subjects or patient data. Therefore, there is no "test set" in the context of patient data; instead, the "test set" refers to the device itself and its components undergoing various engineering evaluations.

    The data provenance is laboratory testing conducted by Venus Concept USA Inc. or its designated testing facilities, likely in the country of manufacture or where the company is headquartered (USA or elsewhere as a global company). The data is generated from prospective testing of the new Venus Viva™ device against established standards and comparisons to predicate device specifications.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This type of information is not applicable to the submission described. The "ground truth" here is objective engineering specifications, regulatory standards (e.g., IEC standards for electrical safety), and verified characteristics of the predicate devices. These are established through established scientific and engineering principles, not through expert human interpretation of results like in a diagnostic study.

    4. Adjudication Method (e.g., 2+1, 3+1, none) for the Test Set

    This information is not applicable. Adjudication methods like 2+1 (two readers agree, third adjudicates if they disagree) are relevant for clinical studies where human readers interpret data (e.g., medical images) to establish ground truth or assess performance. The tests described are objective engineering measurements and compliance evaluations.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    There was no MRMC comparative effectiveness study and the device is not an AI/CAD (Computer-Aided Detection/Diagnosis) device. It is an electrosurgical cutting and coagulation device. Therefore, this section is not applicable.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This is not an algorithm-only device. It is a physical medical device (an electrosurgical unit with applicators) designed for physician use. There is no "standalone" algorithm performance to evaluate in this context. Therefore, this section is not applicable.

    7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)

    The ground truth for the device's performance relies on several objective measures:

    • Engineering Specifications: Pre-defined specifications for RF and PMF output, frequency, power, and other physical parameters.
    • International Standards: Compliance with established IEC standards for electrical safety, EMC, and software lifecycle processes (e.g., IEC 60601-1, IEC 60601-1-2, IEC 60601-2-2, IEC 60601-1-6, IEC 62304).
    • Biocompatibility Standards: Compliance with ISO 10993-1.
    • Predicate Device Data: The established performance, safety, and effectiveness of the legally marketed predicate devices (Venus Viva™ SR K150161 and Venus Legacy BX K142910).

    8. The Sample Size for the Training Set

    There is no "training set" in the context of patient data or machine learning for this device. The device itself is "trained" during its manufacturing and calibration processes to meet the specified engineering parameters and operate reliably. This is not a machine learning or AI device that undergoes training with data.

    9. How the Ground Truth for the Training Set Was Established

    As there is no "training set" in the context of patient data for machine learning, this question is not applicable. The "ground truth" for the device's operational parameters is established through its design specifications, calibration procedures, and testing against known physical and safety standards during its development and manufacturing.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1